295 related articles for article (PubMed ID: 31821092)
21. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma.
Yu X; Zhang Q; Gao F; Zhang M; Zheng Q; He Y; Guo W
Sci Rep; 2021 Sep; 11(1):17529. PubMed ID: 34471186
[TBL] [Abstract][Full Text] [Related]
22. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
[TBL] [Abstract][Full Text] [Related]
23. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
24. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
25. CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma.
Zhao R; Ni J; Lu S; Jiang S; You L; Liu H; Shou J; Zhai C; Zhang W; Shao S; Yang X; Pan H; Han W
Aging (Albany NY); 2019 Oct; 11(19):8484-8501. PubMed ID: 31584877
[TBL] [Abstract][Full Text] [Related]
26. Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis.
Wang H; Lu L; Liang X; Chen Y
Cancer Immunol Immunother; 2022 Jul; 71(7):1757-1769. PubMed ID: 34854950
[TBL] [Abstract][Full Text] [Related]
27. Development of an autophagy-related signature in pancreatic adenocarcinoma.
Yue P; Zhu C; Gao Y; Li Y; Wang Q; Zhang K; Gao S; Shi Y; Wu Y; Wang B; Xie J; Meng X
Biomed Pharmacother; 2020 Jun; 126():110080. PubMed ID: 32203889
[TBL] [Abstract][Full Text] [Related]
28. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
[TBL] [Abstract][Full Text] [Related]
29. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
[TBL] [Abstract][Full Text] [Related]
30. An immune-related gene prognostic risk index for pancreatic adenocarcinoma.
Su Y; Qi R; Li L; Wang X; Li S; Zhao X; Hou R; Ma W; Liu D; Zheng J; Shi M
Front Immunol; 2022; 13():945878. PubMed ID: 35958614
[TBL] [Abstract][Full Text] [Related]
31. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.
Wang LX; Li Y; Chen GZ
PLoS One; 2018; 13(1):e0190447. PubMed ID: 29377892
[TBL] [Abstract][Full Text] [Related]
32. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
Zhu B; Huo R; Zhi Q; Zhan M; Chen X; Hua ZC
J Trace Elem Med Biol; 2021 May; 65():126734. PubMed ID: 33631610
[TBL] [Abstract][Full Text] [Related]
34. Integrated analyses identify potential prognostic markers for uveal melanoma.
Ni Y; Zhang Z; Chen G; Long W; Tong L; Zeng J
Exp Eye Res; 2019 Oct; 187():107780. PubMed ID: 31469983
[TBL] [Abstract][Full Text] [Related]
35. A study on the role of Taxifolin in inducing apoptosis of pancreatic cancer cells: screening results using weighted gene co-expression network analysis.
Chen SJ; Ren LK; Fei XB; Liu P; Wang X; Zhu CH; Pan YZ
Aging (Albany NY); 2024 Feb; 16(3):2617-2637. PubMed ID: 38305809
[TBL] [Abstract][Full Text] [Related]
36. Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis.
Wang W; Xing H; Huang C; Pan H; Li D
Med Oncol; 2020 Mar; 37(4):33. PubMed ID: 32200436
[TBL] [Abstract][Full Text] [Related]
37. BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma.
Zhu Y; Zhang C; Zhao D; Li W; Zhao Z; Yao S; Zhao D
Dis Markers; 2021; 2021():7842035. PubMed ID: 34777634
[TBL] [Abstract][Full Text] [Related]
38. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
[TBL] [Abstract][Full Text] [Related]
39. Construction of a Competitive Endogenous RNA Network for Pancreatic Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis and a Prognosis Model.
Wang J; Xiang J; Li X
Front Bioeng Biotechnol; 2020; 8():515. PubMed ID: 32548103
[TBL] [Abstract][Full Text] [Related]
40. Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.
Dong Y; Tian J; Yan B; Lv K; Li J; Fu D
Pathol Oncol Res; 2021; 27():1609822. PubMed ID: 34290570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
